Imugene Ltd
IMU
Company Profile
Business description
Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its product includes HER-Vaxx,PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being the Research and Development of oncolytic immunotherapies.
Contact
4-6 Bligh Street
Suite 12.01, Level 12
Sydney NSW 2000
AUSSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
5
Stocks News & Analysis
stocks
How to avoid dividend disaster
Thinking about common reasons a company might stop paying a dividend can help income investors avoid disappointment.
stocks
Aussie tech leader reports earnings
Positive signs of revenue growth being converted into positive cash flow.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,932.00 | 25.40 | 0.32% |
| CAC 40 | 8,065.15 | 23.09 | -0.29% |
| DAX 40 | 18,118.32 | 42.69 | -0.24% |
| Dow JONES (US) | 38,386.09 | 146.43 | 0.38% |
| FTSE 100 | 8,147.03 | 7.20 | 0.09% |
| HKSE | 17,757.54 | 10.63 | 0.06% |
| NASDAQ | 15,983.08 | 55.18 | 0.35% |
| Nikkei 225 | 38,405.66 | 470.90 | 1.24% |
| NZX 50 Index | 11,957.50 | 41.26 | 0.35% |
| S&P 500 | 5,116.17 | 16.21 | 0.32% |
| S&P/ASX 200 | 7,664.10 | 26.70 | 0.35% |
| SSE Composite Index | 3,109.95 | 3.10 | -0.10% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Worley Ltd WOR | 15.09 | 1.22 | -7.48% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 3.03% |
| Tietto Minerals Ltd TIE | 0.68 | 0.00 | 0.00% |
| Pilbara Minerals Ltd PLS | 4.06 | 0.10 | 2.53% |
| Mesoblast Ltd MSB | 0.99 | 0.10 | -8.76% |
| South32 Ltd S32 | 3.59 | 0.08 | 2.28% |
| Imugene Ltd IMU | 0.09 | 0.01 | 6.10% |
| Telstra Group Ltd TLS | 3.67 | 0.01 | 0.27% |
| Core Lithium Ltd CXO | 0.15 | 0.01 | 3.57% |
| Liontown Resources Ltd LTR | 1.25 | 0.04 | 2.89% |